Literature DB >> 22076079

Extracellular chaperones.

Rebecca A Dabbs1, Amy R Wyatt, Justin J Yerbury, Heath Ecroyd, Mark R Wilson.   

Abstract

The maintenance of the levels and correct folding state of proteins (proteostasis) is a fundamental prerequisite for life. Life has evolved complex mechanisms to maintain proteostasis and many of these that operate inside cells are now well understood. The same cannot yet be said of corresponding processes in extracellular fluids of the human body, where inappropriate protein aggregation is known to underpin many serious diseases such as Alzheimer's disease, type II diabetes and prion diseases. Recent research has uncovered a growing family of abundant extracellular chaperones in body fluids which appear to selectively bind to exposed regions of hydrophobicity on misfolded proteins to inhibit their toxicity and prevent them from aggregating to form insoluble deposits. These extracellular chaperones are also implicated in clearing the soluble, stabilized misfolded proteins from body fluids via receptor-mediated endocytosis for subsequent lysosomal degradation. Recent work also raises the possibility that extracellular chaperones may play roles in modulating the immune response. Future work will better define the in vivo functions of extracellular chaperones in proteostasis and immunology and pave the way for the development of new treatments for serious diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22076079     DOI: 10.1007/128_2011_262

Source DB:  PubMed          Journal:  Top Curr Chem        ISSN: 0340-1022


  9 in total

1.  The heat shock response is modulated by and interferes with toxic effects of scrapie prion protein and amyloid β.

Authors:  Ulrike K Resenberger; Veronika Müller; Lisa M Munter; Michael Baier; Gerd Multhaup; Mark R Wilson; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  J Biol Chem       Date:  2012-10-31       Impact factor: 5.157

Review 2.  Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 3.  Clusterin, other extracellular chaperones, and eye disease.

Authors:  Mark R Wilson; Sandeep Satapathy; Shinwu Jeong; M Elizabeth Fini
Journal:  Prog Retin Eye Res       Date:  2021-12-10       Impact factor: 19.704

4.  Characterization of Plasma SDS-Protein Aggregation Profile of Patients with Heart Failure with Preserved Ejection Fraction.

Authors:  Marisol Gouveia; Cristine Schmidt; Manuel Teixeira; Mário Lopes; Susana S Aveiro; Pedro Domingues; Ke Xia; Wilfredo Colón; Rui Vitorino; Rita Ferreira; Mário Santos; Sandra Vieira; Fernando Ribeiro
Journal:  J Cardiovasc Transl Res       Date:  2022-10-21       Impact factor: 3.216

Review 5.  Advances in blood-based protein biomarkers for Alzheimer's disease.

Authors:  Lorraine Fuhrmann Clark; Thomas Kodadek
Journal:  Alzheimers Res Ther       Date:  2013-05-09       Impact factor: 6.982

Review 6.  Molecular chaperones and proteostasis regulation during redox imbalance.

Authors:  Katerina Niforou; Christina Cheimonidou; Ioannis P Trougakos
Journal:  Redox Biol       Date:  2014-01-30       Impact factor: 11.799

7.  Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro.

Authors:  Daisaku Ozawa; Ryo Nomura; P Patrizia Mangione; Kazuhiro Hasegawa; Tadakazu Okoshi; Riccardo Porcari; Vittorio Bellotti; Hironobu Naiki
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

Review 8.  Stress-responsive regulation of extracellular proteostasis.

Authors:  Jaleh S Mesgarzadeh; Joel N Buxbaum; R Luke Wiseman
Journal:  J Cell Biol       Date:  2022-02-22       Impact factor: 10.539

Review 9.  The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism.

Authors:  Chiara Sanguinetti; Marianna Minniti; Vanessa Susini; Laura Caponi; Giorgia Panichella; Vincenzo Castiglione; Alberto Aimo; Michele Emdin; Giuseppe Vergaro; Maria Franzini
Journal:  Biomedicines       Date:  2022-08-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.